🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label treatment program following basic prescribing informa...
Status
Completed
Location
Greater Baltimore Medical Center
Start Date
2017-09-07
Trial ID
NCT03285802
Treatments Being Tested
This is an open-label, mono-center phase I/II study designed to determine t...
Status
Unknown
Location
Charité, university medicine, Berlin, CCM
Start Date
2009-02
Trial ID
NCT00930475
RATIONALE: Sorafenib and everolimus may stop the growth of cancer cells by ...
Status
Completed
Location
Holden Comprehensive Cancer Center at University of Iowa
Start Date
2007-08-29
Trial ID
NCT00474929
Adult patients with gastric carcinoma which has progressed after initial tr...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2011-10
Trial ID
NCT01248403
Treatments Being Tested
Currently looking for individuals that have received a kidney transplant, a...
Status
Terminated
Location
The Ohio State Universtiy Wexner Medical Center
Start Date
2014-04
Trial ID
NCT02134288
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of everolim...
Status
Terminated
Location
2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital
Start Date
2012-08-06
Trial ID
NCT01648465
Treatments Being Tested
A phase I clinical study in evaluation of RAD 001 with aracytine and daunor...
Status
Completed
Location
Sophie Park
Start Date
2008-02
Trial ID
NCT01074086
Treatments Being Tested
This 2 step study aims to establish a tolerable dose level and regimen of R...
Status
Completed
Location
Georgetown University/Lombardi Cancer Center StudyCoordinator:CRAD001C2114
Start Date
2007-02
Trial ID
NCT00457119
Treatments Being Tested
This study is a single-arm exploratory trial conducted by Xuanwu Hospital, ...
Status
Recruiting
Location
the Department of Neurosurgery, China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University
Start Date
2025-07-01
Trial ID
NCT07037238
Treatments Being Tested
Primary objectives: A. To evaluate the effect of Zortress® versus standard ...
Status
Withdrawn
Location
University of Kentucky
Start Date
2012-05
Trial ID
NCT01612299
Treatments Being Tested